コーパス検索結果 (left1)
通し番号をクリックするとPubMedの該当ページを表示します
6 Staphylococcus species (eg, S epidermidis, S capitis, S aureus), and enrichment in metabolic pathways
7 Staphylococcus species (eg, S epidermidis, S capitis, S aureus), and enrichment in metabolic pathways
9 gy was SE (76.8%), followed by SL (6.4%), S. capitis (3.5%), S. haemolyticus (3.2%), S. hominis (3.2%
12 common staphylococcal strains (S. aureus, S. capitis, S. epidermidis, S. haemolyticus, S. hominis, S.
13 vered a strain of Staphylococcus capitis (S. capitis E12) that selectively inhibited growth of C. acn
19 not toxic to human keratinocytes and the S. capitis extract did not kill other commensal skin bacter
20 entify potential therapeutic targets, the S. capitis genome was probed for the presence of genes enco
22 (occipitalis, splenius capitis, semispinalis capitis, and trapezius muscles-all located on one side o
24 n the sternocleidomastoid (SCM) and splenius capitis (SPL) muscles of eight patients with rotational
25 ection of botulinum toxin into each splenius capitis muscle on day 0 and during week 12 was more effe
26 lectromyographic guidance into each splenius capitis muscle on the day of randomization (day 0) and d
27 to four muscle groups (occipitalis, splenius capitis, semispinalis capitis, and trapezius muscles-all
28 tivity of single motor units in the splenius capitis and sternocleidomastoid muscles in rhesus monkey
31 ics we discovered a strain of Staphylococcus capitis (S. capitis E12) that selectively inhibited grow
40 ermoscopy may enhance the diagnosis of tinea capitis and be of help to better understand some pathoge
41 to evaluate the dermoscopic aspects of tinea capitis at high magnification (x150) and its diagnostic
42 soudanense, which are common causes of tinea capitis in parts of Africa and West Asia, have only rare
43 suggesting an increasing incidence of tinea capitis in some areas and increasing clinical failure ra
45 nces in the diagnosis and treatment of tinea capitis include a renewed interest in the use of the cot
46 fectious diseases, the epidemiology of tinea capitis is in a constant state of flux and varies consid
48 that have investigated the response of tinea capitis to griseofulvin, the mainstay treatment for this
49 g new medications for the treatment of tinea capitis, including terbinafine, itraconazole, and flucon
52 yte isolates obtained from a worldwide tinea capitis trial were compared to their susceptibilities to